Twist Bioscience Overview
- Year Founded
-
2013
- Status
-
Public
- Employees
-
923
- Stock Symbol
-
TWST
- Investments
-
7
- Share Price
-
$29.52
- (As of Wednesday Closing)
Twist Bioscience General Information
Description
Twist Bioscience Corp is a synthetic biology company. It develops a disruptive DNA synthesis platform to industrialize the engineering of biology. The company's DNA synthesis platform utilizes a proprietary semiconductor-based synthetic DNA manufacturing process that synthesizes DNA on silicon instead of on traditional well-plastic plates to enable the production of high-quality synthetic DNA faster and affordable as well as overcomes inefficiencies and powers cost-effective, rapid high-throughput synthesis, enabling researchers to realize opportunities ahead rapidly. Geographically, it derives a majority of its revenue from the United States.
Contact Information
Website
www.twistbioscience.comCorporate Office
- 681 Gateway Boulevard
- South San Francisco, CA 94080
- United States
Corporate Office
- 681 Gateway Boulevard
- South San Francisco, CA 94080
- United States
Twist Bioscience Stock Performance
As of 14-May-2025, Twist Bioscience’s stock price is $29.52. Its current market cap is $1.77B with 59.9M shares.
(As of Wednesday Closing)
| Stock Price | Previous Close | 52 wk Range | Market Cap | Shares | Average Volume | EPS |
|---|---|---|---|---|---|---|
| $29.52 | $32.29 | $29.45 - $60.90 | $1.77B | 59.9M | 1.21M | -$3.25 |
Twist Bioscience Financials Summary
As of 31-Mar-2025, Twist Bioscience has a trailing 12-month revenue of $348M.
|
In Thousands, USD |
TTM 31-Mar-2025 | FY 2024 30-Sep-2024 | FY 2023 30-Sep-2023 | FY 2022 30-Sep-2022 |
|---|---|---|---|---|
| EV | 2,153,693 | 2,444,676 | 898,733 | 1,537,255 |
| Revenue | 347,680 | 312,974 | 245,109 | 203,565 |
| EBITDA | (176,170) | (192,049) | (188,516) | (214,742) |
| Net Income | (191,148) | (208,726) | (204,618) | (217,863) |
| Total Assets | 595,615 | 614,323 | 776,403 | 961,378 |
| Total Debt | 80,298 | 85,026 | 94,069 | 94,912 |
Twist Bioscience Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
Twist Bioscience Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price |
% Owned |
|---|
Twist Bioscience Comparisons
Industry
Financing
Details
Twist Bioscience Competitors (27)
One of Twist Bioscience’s 27 competitors is Pacific Biosciences, a Formerly VC-backed company based in Menlo Park, CA.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Pacific Biosciences | Formerly VC-backed | Menlo Park, CA | ||||
| Deep Genomics | Venture Capital-Backed | Toronto, Canada | ||||
| CustomArray | Corporate Backed or Acquired | Redmond, WA | ||||
| HTG Molecular Diagnostics | Formerly VC-backed | Tucson, AZ | ||||
| Tempus AI | Formerly VC-backed | Chicago, IL |
Twist Bioscience Related Research & Analysis
Explore institutional-grade private market research from our team of analysts.
-
Verticals
.png)
Twist Bioscience Patents
Twist Bioscience Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| EP-4511836-A2 | Codecs for dna data storage | Pending | 21-Apr-2022 | ||
| AU-2023255494-A1 | Codecs for dna data storage | Pending | 21-Apr-2022 | ||
| AU-2023249258-A1 | Substrate cleavage for nucleic acid synthesis | Pending | 07-Apr-2022 | ||
| EP-4504959-A1 | Substrate cleavage for nucleic acid synthesis | Pending | 07-Apr-2022 | ||
| AU-2023245564-A1 | Libraries for methylation analysis | Pending | 01-Apr-2022 | C12Q1/6827 |
Twist Bioscience Signals
Growth Rate
Growth
Size Multiple
Key Data Points
Similarweb Unique Visitors
Majestic Referring Domains
Twist Bioscience Investments & Acquisitions (7)
Twist Bioscience’s most recent deal was a Later Stage VC with Camena Bioscience for . The deal was made on 03-Jul-2023.
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| Camena Bioscience | 03-Jul-2023 | Later Stage VC | Biotechnology | ||
| Revelar Biotherapeutics | 09-May-2022 | Seed Round | Drug Discovery | ||
| Abveris | 01-Dec-2021 | Merger/Acquisition | Drug Discovery | ||
| Revelar Biotherapeutics | 01-Nov-2021 | Corporate | Drug Discovery | ||
| iGenomX | 14-Jun-2021 | Merger/Acquisition | Discovery Tools (Healthcare) |
Twist Bioscience ESG
Risk Overview
Risk Rating
Updated April, 01, 2025
29.9 | Med Risk
Risk Scale
A lower score indicates better sustainability
Negl
0-10
Low
10-20
Med
20-30
High
30-40
Severe
40+
Exposure
Exposure refers to the extent to which a company is exposed to different material ESG issues
Management
Management is related to actions taken to manage ESG issues
Peers Analysis
Peer performance insights compare the company’s ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements.
Global
Covered Companies
of 14,631
Rank
Percentile
Pharmaceuticals
Industry
of 843
Rank
Percentile
Biotechnology
Subindustry
of 365
Rank
Percentile
Twist Bioscience Exits (2)
Twist Bioscience’s most recent exit was on 09-May-2022 from Revelar Biotherapeutics. The exit was categorized as with 2 buyers.
| Company Name | Exit Date | Exit Type | Exit Size | Status | Buyers |
|---|---|---|---|---|---|
| Revelar Biotherapeutics | 09-May-2022 | Completed |
|
||
| Revelar Biotherapeutics | 01-Nov-2021 | Corporate | Completed |
Twist Bioscience Affiliates
Subsidiaries (1)
| Name | Industry | Location | Year Founded |
|---|---|---|---|
| Abveris | Quincy, MA | 2017 |
Twist Bioscience FAQs
-
When was Twist Bioscience founded?
Twist Bioscience was founded in 2013.
-
Where is Twist Bioscience headquartered?
Twist Bioscience is headquartered in South San Francisco, CA.
-
What is the size of Twist Bioscience?
Twist Bioscience has 923 total employees.
-
What industry is Twist Bioscience in?
Twist Bioscience’s primary industry is Drug Discovery.
-
Is Twist Bioscience a private or public company?
Twist Bioscience is a Public company.
-
What is Twist Bioscience’s stock symbol?
The ticker symbol for Twist Bioscience is TWST.
-
What is the current stock price of Twist Bioscience?
As of 14-May-2025 the stock price of Twist Bioscience is $29.52.
-
What is the current market cap of Twist Bioscience?
The current market capitalization of Twist Bioscience is $1.77B.
-
What is Twist Bioscience’s current revenue?
The trailing twelve month revenue for Twist Bioscience is $348M.
-
Who are Twist Bioscience’s competitors?
Pacific Biosciences, Deep Genomics, CustomArray, HTG Molecular Diagnostics, and Tempus AI are some of the 27 competitors of Twist Bioscience.
-
What is Twist Bioscience’s annual earnings per share (EPS)?
Twist Bioscience’s EPS for 12 months was -$3.25.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read blog » -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process »
